Major competitors identified in this market include CytoPharma, Bristol-Myers Squibb, Amgen, Celgene Corp, Eli Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline PLC, Johnson and Johnson, Lonza, Merck, Novartis, Pfizer, Sanofi, Teva Pharmaceutical, etc.

Based on the Region:

Asia-Pacific (China, Japan, South Korea, India and ASEAN)

North America (US and Canada)

Europe (Germany, France, UK and Italy)

Rest of World (Latin America, Middle East & Africa)

Based on the Type:

Alkylating Agents

Antitumor Antibiotics

Antimetabolites

Plant Alkaloids

Others

Based on the Application:

Hospital

Cancer Research Center

Drug Testing Laboratory

CDMOs

FEATURED COMPANIES

Eli Lilly and Company

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Cytotoxic Drugs Industry

1.7 COVID-19 Impact: Cytotoxic Drugs Market Trends

2 Global Cytotoxic Drugs Quarterly Market Size Analysis

2.1 Cytotoxic Drugs Business Impact Assessment - COVID-19

2.1.1 Global Cytotoxic Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Cytotoxic Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Cytotoxic Drugs Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Cytotoxic Drugs Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Cytotoxic Drugs Factory Price by Manufacturers

3.3 Location of Key Manufacturers Cytotoxic Drugs Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Cytotoxic Drugs Market

3.5 Key Manufacturers Cytotoxic Drugs Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Cytotoxic Drugs Segments, By Type

4.1 Introduction

1.4.1 Alkylating Agents

1.4.2 Antitumor Antibiotics

1.4.3 Antimetabolites

1.4.4 Plant Alkaloids

1.4.5 Others

4.2 By Type, Global Cytotoxic Drugs Market Size, 2019-2021

4.2.1 By Type, Global Cytotoxic Drugs Market Size by Type, 2020-2021

4.2.2 By Type, Global Cytotoxic Drugs Price, 2020-2021

5 Impact of Covid-19 on Cytotoxic Drugs Segments, By Application

5.1 Overview

5.5.1 Hospital

5.5.2 Cancer Research Center

5.5.3 Drug Testing Laboratory

5.5.4 CDMOs

5.2 By Application, Global Cytotoxic Drugs Market Size, 2019-2021

5.2.1 By Application, Global Cytotoxic Drugs Market Size by Application, 2019-2021

5.2.2 By Application, Global Cytotoxic Drugs Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 CytoPharma

7.1.1 CytoPharma Business Overview

7.1.2 CytoPharma Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.1.3 CytoPharma Cytotoxic Drugs Product Introduction

7.1.4 CytoPharma Response to COVID-19 and Related Developments

7.2 Bristol-Myers Squibb

7.2.1 Bristol-Myers Squibb Business Overview

7.2.2 Bristol-Myers Squibb Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.2.3 Bristol-Myers Squibb Cytotoxic Drugs Product Introduction

7.2.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments

7.3 Amgen

7.3.1 Amgen Business Overview

7.3.2 Amgen Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.3.3 Amgen Cytotoxic Drugs Product Introduction

7.3.4 Amgen Response to COVID-19 and Related Developments

7.4 Celgene Corp

7.4.1 Celgene Corp Business Overview

7.4.2 Celgene Corp Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.4.3 Celgene Corp Cytotoxic Drugs Product Introduction

7.4.4 Celgene Corp Response to COVID-19 and Related Developments

7.5 Eli Lilly and Company

7.5.1 Eli Lilly and Company Business Overview

7.5.2 Eli Lilly and Company Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.5.3 Eli Lilly and Company Cytotoxic Drugs Product Introduction

7.5.4 Eli Lilly and Company Response to COVID-19 and Related Developments

7.6 F. Hoffmann-La Roche

7.6.1 F. Hoffmann-La Roche Business Overview

7.6.2 F. Hoffmann-La Roche Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.6.3 F. Hoffmann-La Roche Cytotoxic Drugs Product Introduction

7.6.4 F. Hoffmann-La Roche Response to COVID-19 and Related Developments

7.7 GlaxoSmithKline PLC

7.7.1 GlaxoSmithKline PLC Business Overview

7.7.2 GlaxoSmithKline PLC Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.7.3 GlaxoSmithKline PLC Cytotoxic Drugs Product Introduction

7.7.4 GlaxoSmithKline PLC Response to COVID-19 and Related Developments

7.8 Johnson and Johnson

7.8.1 Johnson and Johnson Business Overview

7.8.2 Johnson and Johnson Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.8.3 Johnson and Johnson Cytotoxic Drugs Product Introduction

7.8.4 Johnson and Johnson Response to COVID-19 and Related Developments

7.9 Lonza

7.9.1 Lonza Business Overview

7.9.2 Lonza Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.9.3 Lonza Cytotoxic Drugs Product Introduction

7.9.4 Lonza Response to COVID-19 and Related Developments

7.10 Merck

7.10.1 Merck Business Overview

7.10.2 Merck Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.10.3 Merck Cytotoxic Drugs Product Introduction

7.10.4 Merck Response to COVID-19 and Related Developments

7.11 Novartis

7.11.1 Novartis Business Overview

7.11.2 Novartis Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.11.3 Novartis Cytotoxic Drugs Product Introduction

7.11.4 Novartis Response to COVID-19 and Related Developments

7.12 Pfizer

7.12.1 Pfizer Business Overview

7.12.2 Pfizer Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.12.3 Pfizer Cytotoxic Drugs Product Introduction

7.12.4 Pfizer Response to COVID-19 and Related Developments

7.13 Sanofi

7.13.1 Sanofi Business Overview

7.13.2 Sanofi Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.13.3 Sanofi Cytotoxic Drugs Product Introduction

7.13.4 Sanofi Response to COVID-19 and Related Developments

7.14 Teva Pharmaceutical

7.14.1 Teva Pharmaceutical Business Overview

7.14.2 Teva Pharmaceutical Cytotoxic Drugs Quarterly Production and Revenue, 2020

7.14.3 Teva Pharmaceutical Cytotoxic Drugs Product Introduction

7.14.4 Teva Pharmaceutical Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Cytotoxic Drugs Supply Chain Analysis

8.1.1 Cytotoxic Drugs Supply Chain Analysis

8.1.2 Covid-19 Impact on Cytotoxic Drugs Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Cytotoxic Drugs Distribution Channels

8.2.2 Covid-19 Impact on Cytotoxic Drugs Distribution Channels

8.2.3 Cytotoxic Drugs Distributors

8.3 Cytotoxic Drugs Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

FEATURED COMPANIES

Eli Lilly and Company

List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Cytotoxic Drugs Assessment

Table 9. COVID-19 Impact: Cytotoxic Drugs Market Trends

Table 10. COVID-19 Impact Global Cytotoxic Drugs Market Size

Table 11. Global Cytotoxic Drugs Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (MT)

Table 12. Global Cytotoxic Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Kg)

Table 13. Global Cytotoxic Drugs Quarterly Market Size, 2020 (US$ Million) & (MT)

Table 14. Global Cytotoxic Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Cytotoxic Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (MT)

Table 16. Global Cytotoxic Drugs Market Growth Drivers

Table 17. Global Cytotoxic Drugs Market Restraints

Table 18. Global Cytotoxic Drugs Market Opportunities

Table 19. Global Cytotoxic Drugs Market Challenges

Table 20. Key Manufacturers Cytotoxic Drugs Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Cytotoxic Drugs Market Size, 2019 (MT) & (US$ Million)

Table 22. Cytotoxic Drugs Factory Price by Manufacturers 2020 (USD/Kg)

Table 23. Location of Key Manufacturers Cytotoxic Drugs Manufacturing Plants

Table 24. Key Manufacturers Cytotoxic Drugs Market Served

Table 25. Date of Key Manufacturers Enter into Cytotoxic Drugs Market

Table 26. Key Manufacturers Cytotoxic Drugs Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Cytotoxic Drugs Market Size by Type, 2020, (US$ Million)

Table 29. Global Cytotoxic Drugs Market Size by Type, 2020 (MT)

Table 30. Global Cytotoxic Drugs Price: by Type, 2020-2021 (USD/Kg)

Table 31. Global Cytotoxic Drugs Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Cytotoxic Drugs Market Size by Application, 2020-2021 (MT)

Table 33. Global Cytotoxic Drugs Price: by Application, 2020-2021 (USD/Kg)

Table 34. Global Cytotoxic Drugs Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Cytotoxic Drugs Market Size by Region, 2019-2021 (MT)

Table 36. By Country, North America Cytotoxic Drugs Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Cytotoxic Drugs Market Size, 2019-2021 (MT)

Table 38. US Cytotoxic Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 39. Canada Cytotoxic Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Cytotoxic Drugs Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Cytotoxic Drugs Market Size, 2019-2021 (MT)

Table 43. Germany Cytotoxic Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 44. France Cytotoxic Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 45. UK Cytotoxic Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 46. Italy Cytotoxic Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Cytotoxic Drugs Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Cytotoxic Drugs Market Size, 2019-2021 (MT)

Table 50. China Cytotoxic Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 51. Japan Cytotoxic Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 52. South Korea Cytotoxic Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 53. India Cytotoxic Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 54. ASEAN Cytotoxic Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 55. Latin America Cytotoxic Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 56. Middle East and Africa Cytotoxic Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 57. CytoPharma Business Overview

Table 58. CytoPharma Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. CytoPharma Cytotoxic Drugs Product

Table 60. CytoPharma Response to COVID-19 and Related Developments

Table 61. Bristol-Myers Squibb Business Overview

Table 62. Bristol-Myers Squibb Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Bristol-Myers Squibb Cytotoxic Drugs Product

Table 64. Bristol-Myers Squibb Response to COVID-19 and Related Developments

Table 65. Amgen Business Overview

Table 66. Amgen Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Amgen Cytotoxic Drugs Product

Table 68. Amgen Response to COVID-19 and Related Developments

Table 69. Celgene Corp Business Overview

Table 70. Celgene Corp Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Celgene Corp Cytotoxic Drugs Product

Table 72. Celgene Corp Response to COVID-19 and Related Developments

Table 73. Eli Lilly and Company Business Overview

Table 74. Eli Lilly and Company Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Eli Lilly and Company Cytotoxic Drugs Product

Table 76. Eli Lilly and Company Response to COVID-19 and Related Developments

Table 77. F. Hoffmann-La Roche Business Overview

Table 78. F. Hoffmann-La Roche Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. F. Hoffmann-La Roche Cytotoxic Drugs Product

Table 80. F. Hoffmann-La Roche Response to COVID-19 and Related Developments

Table 81. GlaxoSmithKline PLC Business Overview

Table 82. GlaxoSmithKline PLC Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. GlaxoSmithKline PLC Cytotoxic Drugs Product

Table 84. GlaxoSmithKline PLC Response to COVID-19 and Related Developments

Table 85. Johnson and Johnson Business Overview

Table 86. Johnson and Johnson Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Johnson and Johnson Cytotoxic Drugs Product

Table 88. Johnson and Johnson Response to COVID-19 and Related Developments

Table 89. Lonza Business Overview

Table 90. Lonza Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Lonza Cytotoxic Drugs Product

Table 92. Lonza Response to COVID-19 and Related Developments

Table 93. Merck Business Overview

Table 94. Merck Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Merck Cytotoxic Drugs Product

Table 96. Merck Response to COVID-19 and Related Developments

Table 97. Novartis Business Overview

Table 98. Novartis Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Novartis Cytotoxic Drugs Product

Table 100. Novartis Response to COVID-19 and Related Developments

Table 101. Pfizer Business Overview

Table 102. Pfizer Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. Pfizer Cytotoxic Drugs Product

Table 104. Pfizer Response to COVID-19 and Related Developments

Table 105. Sanofi Business Overview

Table 106. Sanofi Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. Sanofi Cytotoxic Drugs Product

Table 108. Sanofi Response to COVID-19 and Related Developments

Table 109. Teva Pharmaceutical Business Overview

Table 110. Teva Pharmaceutical Cytotoxic Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 111. Teva Pharmaceutical Cytotoxic Drugs Product

Table 112. Teva Pharmaceutical Response to COVID-19 and Related Developments

Table 113. Cytotoxic Drugs Distributors List

Table 114. Cytotoxic Drugs Customers List

Table 115. Covid-19 Impact on Cytotoxic Drugs Customers

List of Figures

Figure 1. Cytotoxic Drugs Product Picture

Figure 2. Cytotoxic Drugs Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Cytotoxic Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Cytotoxic Drugs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Cytotoxic Drugs Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Cytotoxic Drugs Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Cytotoxic Drugs Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Cytotoxic Drugs Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Cytotoxic Drugs Market Size Market Share, 2019-2021

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3250

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$4875

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Covid-19 Impact on Cytotoxic Drugs Market, Global Research Reports 2020-2021

Published Date: May 2020

Report Code: QYRE-Auto-26C2603

Covid-19 Impact on Cytotoxic Drugs Market, Global Research Reports 2020-2021

FEATURED COMPANIES

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-9U9373

Sat Sep 23 00:00:00 UTC 2023

120 Pages

Type: Report

Code: QYRE-Auto-38T8768

Sat Sep 23 00:00:00 UTC 2023

120 Pages

Type: Report

Code: QYRE-Auto-37L8796

Sat Sep 23 00:00:00 UTC 2023

120 Pages

Type: Report

Code: QYRE-Auto-3F9131

Sat Sep 23 00:00:00 UTC 2023

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions